Comparative effectiveness of drugs used to constrict the patent ductus arteriosus: a secondary analysis of the PDA-TOLERATE trial (NCT01958320)

OBJECTIVE: To evaluate the effectiveness of drugs used to constrict patent ductus arteriosus (PDA) in newborns <28 weeks. METHODS: We performed a secondary analysis of the multi-center PDA-TOLERATE trial (NCT01958320). Infants with moderate-to-large PDAs were randomized 1:1 at 8.1±2.1 days to eit...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Liebowitz, Melissa, Kaempf, Joseph, Erdeve, Omer, Bulbul, Ali, Håkansson, Stellan, Lindqvist, Johanna, Farooqi, Aijaz, Katheria, Anup, Sauberan, Jason, Singh, Jaideep, Nelson, Kelly, Wickremasinghe, Andrea, Dong, Lawrence, Hassinger, Denise C., Aucott, Susan W., Hayashi, Madoka, Heuchan, Anne Marie, Carey, William A., Derrick, Matthew, Wolf, Ilene Sue, Kimball, Amy, Sankar, Meera, Leone, Tina, Perez, Jorge, Serize, Arturo, Clyman, Ronald I.
Fformat: Online Erthygl Texto
Iaith:English
Cyhoeddwyd: 2019
Pynciau:
Article
Mynediad Ar-lein:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561645/
https://www.ncbi.nlm.nih.gov/pubmed/30850756
http://dx.doi.org/10.1038/s41372-019-0347-4

Rhyngrwyd

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561645/
https://www.ncbi.nlm.nih.gov/pubmed/30850756
http://dx.doi.org/10.1038/s41372-019-0347-4

Eitemau Tebyg